Sabadilla
Natural health product licensed in Canada
- Other names
- Enfants 0-9 Nasalya, Enfants 0-9 Sabadilla, Kids 0-9 Nasalya, Kids 0-9 Sabadilla, Nasalya
- Licence holder
- Homeocan Inc.
- NPN or DIN-HM
- 80085387
- Status
- Active licence
- Licence date
- 18 May 2018
- Revision date
- 6 September 2022
- Form
- Liquide oral, solution
- Route of administration
- Orale
- Application type
- Homéopathique
If this product were sold in France
- Information
Homeopathic medicine in Canada, outside the scope of food supplements in France. Nutrient doses are not analysed.
Homéopathique. Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 4 years ; maximum: 11 years | 1 dose unitaire | 3 Tous les jours |
Uses authorised in Canada
Médicament homéopathique pour les symptômes du rhume tels que; l'écoulement nasal, les éternuements, la congestion nasale, les rhinites aigues, à répétition, infectieuses ou allergiques, les frissons et la fièvre modérée. AVERSTISSEMENT - Cette allégation est fondée sur des références homéopathiques traditionnelles et non sur des preuves scientifiques moderns.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soins de santé avant d'en faire l'usage si vous êtes enceinte ou si vous allaitez. Consulter un praticien de soins de santé si les symptômes persistent ou s'aggravent. Si une fièvre persiste au-delà de 3 jours, dépasse 38°C ou est accompagnée de vomissements ou diarrhée fréquents, un mal de tête grave, une raideur de la nuque ou une éruption de la peau, consulter un praticien de soins de santé immédiatement. Garder hors de la portée des enfants. Ne pas utiliser si le sceau de sécurité est brisé.
Source
Official Health Canada record, licence 80085387
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging